Absci is a biotechnology company that applies artificial intelligence and synthetic biology to protein discovery and cell line development. The organization employs about 170 people and has seen a modest net increase in staff, with 16 new hires balanced by 15 departures. This steady headcount reflects measured growth as the company advances its research and platform capabilities.
Engineering is Absci’s largest team, accounting for roughly 57% of total employees with 97 specialists focused on research, data science, and platform development. Business-oriented functions follow, including Business Management (21 employees) and Finance & Administration (15 employees), which together support commercial strategy and internal operations. Scientific and technical support roles such as Healthcare (10), Information Technology (6), and Operations (5) round out the technical backbone. Smaller groups in Program & Project Management (2) and Human Resources (2) handle coordination and people operations, while the Consulting category currently shows no dedicated headcount. An additional 12 employees are classified under Other, covering niche or cross-functional responsibilities.
Absci’s workforce is concentrated in the Pacific Northwest, with Vancouver, Washington hosting 49 employees and nearby Portland, Oregon accounting for 43. The company maintains a multi-site presence across major U.S. biotech hubs: San Francisco (6 employees), San Diego (4), Seattle (3), Boston (5), and Chicago (2). New York City supports 8 employees, and 18 staff members operate in various remote or satellite locations. Austin is listed but presently reports no dedicated headcount. This distributed footprint allows Absci to tap into diverse talent pools while keeping a significant core near its headquarters.